Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine

    loading  Checking for direct PDF access through Ovid

Excerpt

Related Topics

    loading  Loading Related Articles